Caraco begins shipment of generic Optivar

DETROIT Generic drug maker Caraco Pharmaceutical Labs has begun shipping azelastine ophthalmic solution in the 0.05% strength, Caraco said Tuesday.

The drug, recently approved by the Food and Drug Administration, is used to treat itching of the eyes related to allergic conjunctivitis.

The drug is a generic version of Medpoint Pharmaceuticals’ and Meda Pharmaceuticals’ Optivar, which has annual sales of around $50 million, according to Caraco.

Login or Register to post a comment.